FOI: What is the Gold Standard of Airway Management in the Anticipated Difficult Airway
Sponsor
Johannes Gutenberg University Mainz (Other)
Overall Status
Completed
CT.gov ID
NCT04158323
Collaborator
(none)
60
1
30
60.9
Study Details
Study Description
Brief Summary
A prospective Observationalstudie to analyze the current significance of the awake flexible endoscopy in German hospitals.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The aim of the study is to analyze the current significance of the awake flexible endoscopy in German hospitals, to identify strategies to securing the airway in patients with a anticipated difficult airway. The participants complete a pre-prepared questionnaire.
Study Design
Study Type:
Observational
Actual Enrollment
:
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Survey on the Current Significance of the Flexible Endoscopy as the Gold Standard for Airway Management in Patients With Anticipated Difficult Airway
Actual Study Start Date
:
Nov 23, 2019
Actual Primary Completion Date
:
Dec 23, 2019
Actual Study Completion Date
:
Dec 23, 2019
Outcome Measures
Primary Outcome Measures
- What is the current practice for Airway Management in patients with a anticipated difficult airway? [through study completion, an average of 10 minutes]
Evaluation of the current practice to secure the airway in patients with a anticipated difficult airway
Secondary Outcome Measures
- What is the most preferred technique for awake flexible endoscopy? [through study completion, an average of 10 minutes]
Evaluation of application (nasal/oral), local anesthestics
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- experience in anesthesia or intensive care
Exclusion Criteria:
- no
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University | Mainz | Rhineland-Palatinate | Germany | D55131 |
Sponsors and Collaborators
- Johannes Gutenberg University Mainz
Investigators
- Principal Investigator: Marc Kriege, MD, University Medical Center Mainz
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Marc Kriege, MD,
Principal Investigator,
Johannes Gutenberg University Mainz
ClinicalTrials.gov Identifier:
NCT04158323
Other Study ID Numbers:
- JohannesGUF
First Posted:
Nov 8, 2019
Last Update Posted:
Dec 24, 2019
Last Verified:
Dec 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marc Kriege, MD,
Principal Investigator,
Johannes Gutenberg University Mainz